Onco-Innovations Limited (NEO:ONCO)

Canada flag Canada · Delayed Price · Currency is CAD
2.070
+0.020 (0.98%)
Jul 23, 2025, 4:00 PM EDT
218.46%
Market Cap 98.68M
Revenue (ttm) 65.29K
Net Income (ttm) -8.49M
Shares Out 54.22M
EPS (ttm) -0.24
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,905
Average Volume 158,929
Open 2.050
Previous Close 2.050
Day's Range 2.050 - 2.070
52-Week Range 0.560 - 2.800
Beta n/a
RSI 56.92
Earnings Date Aug 1, 2025

About Onco-Innovations

Onco-Innovations Limited, a pre-clinical stage biotechnology company, develops drug candidates for cancer treatments. The company’s lead product candidate is ONC010, a novel inhibitor of the DNA repair enzyme a Polynucleotide Kinase 3′-Phosphatase (PNKP) in a nanoparticle formulation based on the drug delivery technology. Onco-Innovations Limited is headquartered in Calgary, Canada. [Read more]

Industry Biological Products, Except Diagnostic Substances
CEO Thomas O’Shaughnessy
Employees 1
Stock Exchange Cboe Canada
Ticker Symbol ONCO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.